Curesponse Secures Additional USD 8 Million Funding for Its Breakthrough Precision Oncology Platform
15 nov. 2021 14h35 HE
|
Curesponse
REẖOVOT, Israel, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Curesponse (www.curesponse.com) has secured additional USD 8 million funding for its breakthrough precision oncology platform. Curesponse is a...
Radionetics Oncology Emerges from Crinetics Pharmaceuticals with a Platform and Deep Pipeline of Nonpeptide Targeted Radiopharmaceutical Drug Candidates for Precision Oncology
18 oct. 2021 16h00 HE
|
Crinetics Pharmaceuticals, Inc.
Co-founded by Crinetics, 5AM Ventures and Frazier Healthcare Partners, the New Company Launches with $30M in Initial Financing Provided by 5AM and Frazier Pipeline is Built from Crinetics’ Core...
Dr. Craig Bunnell Joins Advisory Board of Cancer Diagnostic and Precision Oncology Platform Developer 4D Path
24 août 2021 10h00 HE
|
4D Path
NEWTON, Mass., Aug. 24, 2021 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided pan-cancer diagnostic and precision oncology platform, is pleased to announce that Dr. Craig A....
Global $125+ Billion Precision Medicine Market Competition Forecast & Opportunities to 2026
17 juin 2021 05h28 HE
|
Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Global Precision Medicine Market, By Products and Services (Precision Medicine Platforms, Precision Medicine Tools, Precision Medicine Services), By...
Cellworks CBM Clinical Study Identifies Novel Biomarkers for ATRA Benefit and Failure in AML Patients
04 juin 2021 09h00 HE
|
Cellworks Group, Inc.
SOUTH SAN FRANCISCO, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a world leader in Personalized Medicine in the key therapeutic areas of Oncology and Immunology, today announced...
World-Renowned Cancer Oncologist, Health Consultant and Entrepreneur Dr. Nelson Teich Added to 4D Path’s Distinguished Advisory Board
04 mai 2021 10h00 HE
|
4D Path
NEWTON, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, is pleased to announce that Dr. Nelson Teich, MD,...
HEALTHTECH SOLUTIONS, INC. ANNOUNCES CONTRACT TO ACQUIRE VARIAN BIOPHARMACEUTICALS, A PRECISION ONCOLOGY COMPANY
31 mars 2021 15h11 HE
|
Healthtech Solutions, Inc.
NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Healthtech Solutions, Inc. (OTC: HLTT) (“HLTT” or the “Company”) today announces that it has entered into an agreement to acquire a...
4D Path, University of Leeds Extend Contract to Collaboratively Validate New Technology to Help Doctors More Accurately Diagnose Breast Cancer
16 mars 2021 10h00 HE
|
4D Path
NEWTON, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, has extended its existing partnership with the...
World Genomic Cancer Panel and Profiling Markets by Cancer and Germline/Somatic 2021-2025: New Science Creating New Market Opportunities with Regularity
25 févr. 2021 04h13 HE
|
Research and Markets
Dublin, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The "Genomic Cancer Panel and Profiling Markets by Cancer and Germline/Somatic Type with Screening Potential Market Size, Customized Forecasting/Analysis,...
I-O Therapy Combinations Spurring Growth of the Global Immuno-oncology Market, 2020 Report - Upcoming Product Launches in Adoptive Cell Therapy Segment Hold Future Growth Potential
17 févr. 2021 08h38 HE
|
Research and Markets
Dublin, Feb. 17, 2021 (GLOBE NEWSWIRE) -- The "I-O Therapy Combinations Spurring Growth of the Global Immuno-oncology Market" report has been added to ResearchAndMarkets.com's offering. This...